1. Home
  2. SOPA vs SNGX Comparison

SOPA vs SNGX Comparison

Compare SOPA & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOPA
  • SNGX
  • Stock Information
  • Founded
  • SOPA 2018
  • SNGX 1987
  • Country
  • SOPA Singapore
  • SNGX United States
  • Employees
  • SOPA N/A
  • SNGX N/A
  • Industry
  • SOPA EDP Services
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOPA Technology
  • SNGX Health Care
  • Exchange
  • SOPA Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • SOPA 3.8M
  • SNGX 4.3M
  • IPO Year
  • SOPA 2021
  • SNGX 1987
  • Fundamental
  • Price
  • SOPA $1.39
  • SNGX $3.38
  • Analyst Decision
  • SOPA Strong Buy
  • SNGX Strong Buy
  • Analyst Count
  • SOPA 1
  • SNGX 1
  • Target Price
  • SOPA $15.00
  • SNGX $6.00
  • AVG Volume (30 Days)
  • SOPA 120.8K
  • SNGX 31.7M
  • Earning Date
  • SOPA 08-13-2025
  • SNGX 08-14-2025
  • Dividend Yield
  • SOPA N/A
  • SNGX N/A
  • EPS Growth
  • SOPA N/A
  • SNGX N/A
  • EPS
  • SOPA N/A
  • SNGX N/A
  • Revenue
  • SOPA $7,522,939.00
  • SNGX N/A
  • Revenue This Year
  • SOPA N/A
  • SNGX N/A
  • Revenue Next Year
  • SOPA $45.16
  • SNGX N/A
  • P/E Ratio
  • SOPA N/A
  • SNGX N/A
  • Revenue Growth
  • SOPA 0.31
  • SNGX N/A
  • 52 Week Low
  • SOPA $0.64
  • SNGX $1.09
  • 52 Week High
  • SOPA $6.75
  • SNGX $6.23
  • Technical
  • Relative Strength Index (RSI)
  • SOPA 55.45
  • SNGX 57.23
  • Support Level
  • SOPA $1.10
  • SNGX $2.32
  • Resistance Level
  • SOPA $1.49
  • SNGX $6.23
  • Average True Range (ATR)
  • SOPA 0.15
  • SNGX 0.62
  • MACD
  • SOPA 0.02
  • SNGX 0.04
  • Stochastic Oscillator
  • SOPA 55.57
  • SNGX 27.11

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: